Texas Permanent School Fund’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-11,387
Closed -$191K – 1524
2022
Q4
$191K Sell
11,387
-1,423
-11% -$24.6K ﹤0.01% 1496
2022
Q3
$190K Sell
12,810
-220
-2% -$4.35K ﹤0.01% 1491
2022
Q2
$357K Buy
13,030
+432
+3% +$12.8K 0.01% 1429
2022
Q1
$475K Sell
12,598
-214
-2% -$9.47K 0.01% 1400
2021
Q4
$796K Buy
+12,812
New +$971K 0.01% 1286

Other funds holding OPRX

Texas Permanent School Fund's OPRX Position: Q1 2023 in Review

Texas Permanent School Fund sold out of OptimizeRx (OPRX) in Q1 2023, closing a stake of 11,387 shares — an estimated $191K sold.

Texas Permanent School Fund first reported a position in OPRX in Q4 2021 and held it in 5 quarters. The position peaked at $796K in Q4 2021. 110 funds tracked by Wall St. Rank hold OPRX as of Q1 2023.

  • Texas Permanent School Fund reported no remaining OptimizeRx position as of Q1 2023 after selling out during the quarter.
  • Texas Permanent School Fund sold 11,387 OptimizeRx shares in Q1 2023, an estimated $191K.
  • Texas Permanent School Fund first reported a position in OptimizeRx in Q4 2021 and held it in 5 quarters.
  • Texas Permanent School Fund's OptimizeRx position peaked at $796K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2023.

Based on Texas Permanent School Fund's 13F filing for Q1 2023, filed 1 May 2023.